<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34996976</PMID><DateCompleted><Year>2022</Year><Month>02</Month><Day>23</Day></DateCompleted><DateRevised><Year>2022</Year><Month>02</Month><Day>23</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Jan</Month><Day>07</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>SOD1 mutations associated with amyotrophic lateral sclerosis analysis of variant severity.</ArticleTitle><Pagination><StartPage>103</StartPage><MedlinePgn>103</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">103</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-021-03891-8</ELocationID><Abstract><AbstractText>Mutations in superoxide dismutase 1 gene (SOD1) are linked to amyotrophic lateral sclerosis (ALS), a neurodegenerative disorder&#xa0;predominantly affecting upper and lower motor neurons. The clinical phenotype of ALS shows inter- and intrafamilial heterogeneity. The aim of the study was to analyze the relations between individual SOD1 mutations and the clinical presentation using in silico methods to assess the SOD1 mutations severity. We identified SOD1 causative variants in a group of 915 prospectively tested consecutive Polish ALS patients from a neuromuscular clinical center, performed molecular modeling of mutated SOD1 proteins and in silico analysis of mutation impact on clinical phenotype and survival analysis of associations between mutations and hazard of clinical end-points. Fifteen SOD1 mutations were identified in 21.1% familial and 2.3% sporadic ALS cases. Their effects on SOD1 protein structure and functioning inferred from molecular modeling and in silico analyses correlate well with the clinical data. Molecular modeling results support the hypothesis that folding intermediates rather than mature SOD1 protein give rise to the source of cytotoxic conformations in ALS. Significant associations between type of mutation and clinical end-points were found.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Berdy&#x144;ski</LastName><ForeName>Mariusz</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Laboratory of Neurogenetics, Department of Neurodegenerative Disorders, Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland. m.berdynski@imdik.pan.pl.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Sciences, Neurosciences, Ume&#xe5; University, Ume&#xe5;, Sweden. m.berdynski@imdik.pan.pl.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Miszta</LastName><ForeName>Przemys&#x142;aw</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Faculty of Chemistry, Biological and Chemical Research Centre, University of Warsaw, Warsaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Safranow</LastName><ForeName>Krzysztof</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Medical Chemistry, Pomeranian Medical University, 72 Powsta&#x144;c&#xf3;w Wlkp. Str., 70-111, Szczecin, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andersen</LastName><ForeName>Peter M</ForeName><Initials>PM</Initials><AffiliationInfo><Affiliation>Department of Clinical Sciences, Neurosciences, Ume&#xe5; University, Ume&#xe5;, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morita</LastName><ForeName>Mitsuya</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Neurology, Department of Internal Medicine, Jichi Medical University, Shimotsuke, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Filipek</LastName><ForeName>S&#x142;awomir</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Faculty of Chemistry, Biological and Chemical Research Centre, University of Warsaw, Warsaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#x17b;ekanowski</LastName><ForeName>Cezary</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Laboratory of Neurogenetics, Department of Neurodegenerative Disorders, Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ku&#x17a;ma-Kozakiewicz</LastName><ForeName>Magdalena</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, Medical University of Warsaw, Warsaw, Poland. mkuzma@wum.edu.pl.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neurodegenerative Diseases Research Group, Medical University of Warsaw, Warsaw, Poland. mkuzma@wum.edu.pl.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>SONATA9 [UMO-2015/17/D/NZ2/03712]</GrantID><Agency>Narodowym Centrum Nauki</Agency><Country/></Grant><Grant><GrantID>SOPHIA (5/SOPHIA/JPND/2012)</GrantID><Agency>EU Joint Programme - Neurodegenerative Disease Research</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>01</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000606290">SOD1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056726" MajorTopicYN="N">Genetic Association Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008958" MajorTopicYN="N">Models, Molecular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="Y">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059645" MajorTopicYN="N">Mutation Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062072" MajorTopicYN="N">Patient Acuity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011044" MajorTopicYN="N" Type="Geographic">Poland</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011487" MajorTopicYN="N">Protein Conformation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017510" MajorTopicYN="N">Protein Folding</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013329" MajorTopicYN="N">Structure-Activity Relationship</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>8</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>12</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>1</Month><Day>8</Day><Hour>5</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>1</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>2</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34996976</ArticleId><ArticleId IdType="pmc">PMC8742055</ArticleId><ArticleId IdType="doi">10.1038/s41598-021-03891-8</ArticleId><ArticleId IdType="pii">10.1038/s41598-021-03891-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Byrne S, Walsh C, Lynch C, Bede P, Elamin M, Kenna K, McLaughlin R, Hardiman O. Rate of familial amyotrophic lateral sclerosis: A systematic review and meta-analysis. J. Neurol. Neurosurg. Psychiatry. 2011;82:623&#x2013;627.</Citation><ArticleIdList><ArticleId IdType="pubmed">21047878</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen PM, Al-Chalabi A. Clinical genetics of amyotrophic lateral sclerosis: What do we really know? Nat. Rev. Neurol. 2011;7:603&#x2013;615.</Citation><ArticleIdList><ArticleId IdType="pubmed">21989245</ArticleId></ArticleIdList></Reference><Reference><Citation>Abel O, Powell JF, Andersen PM, Al-Chalabi A. ALSoD: A user-friendly online bioinformatics tool for amyotrophic lateral sclerosis genetics. Hum. Mutat. 2012;33:1345&#x2013;1351.</Citation><ArticleIdList><ArticleId IdType="pubmed">22753137</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghasemi M, Brown RH. Genetics of amyotrophic lateral sclerosis. Cold Spring Harb. Perspect. Med. 2018;8:a024125.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5932579</ArticleId><ArticleId IdType="pubmed">28270533</ArticleId></ArticleIdList></Reference><Reference><Citation>Perrone B, Conforti FL. Common mutations of interest in the diagnosis of amyotrophic lateral sclerosis: How common are common mutations in ALS genes? Expert. Rev. Mol. Diagn. 2020;20:703&#x2013;714.</Citation><ArticleIdList><ArticleId IdType="pubmed">32497448</ArticleId></ArticleIdList></Reference><Reference><Citation>Culik RM, Sekhar A, Nagesh J, Deol H, Rumfeldt JAO, Meiering EM, Kay LE. Effects of maturation on the conformational free-energy landscape of SOD1. Proc. Natl. Acad. Sci. U. S. A. 2018;115:E2546&#x2013;E2555.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5856554</ArticleId><ArticleId IdType="pubmed">29483249</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen PM. Extensive heterogeneity in patients with ALS with mutations in SOD1 in France. J. Neurol Neurosurg. Psychiatry. 2021 doi: 10.1136/jnnp-2021-326553.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2021-326553</ArticleId><ArticleId IdType="pubmed">33906934</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Mot. Neuron Disord. Off. Publ. World Fed. Neurol. Res. Group Mot. Neuron Dis. 2000;1:293&#x2013;299.</Citation><ArticleIdList><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Berdy&#x144;ski M, Ku&#x17a;ma-Kozakiewicz M, Ricci C, Kubiszewska J, Millecamps S, Salachas F, &#x141;usakowska A, Carrera P, Meininger V, Battistini S, Kwieci&#x144;ski H, Zekanowski C. Recurrent G41S mutation in Cu/Zn superoxide dismutase gene (SOD1) causing familial amyotrophic lateral sclerosis in a large Polish family. Amyotroph. Lateral Scler. Off. Publ. World Fed. Neurol. Res. Group Mot. Neuron Dis. 2012;13:132&#x2013;136.</Citation><ArticleIdList><ArticleId IdType="pubmed">21877919</ArticleId></ArticleIdList></Reference><Reference><Citation>McLaren W, Gil L, Hunt SE, Riat HS, Ritchie GRS, Thormann A, Flicek P, Cunningham F. The ensembl variant effect predictor. Genome Biol. 2016;17:122.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4893825</ArticleId><ArticleId IdType="pubmed">27268795</ArticleId></ArticleIdList></Reference><Reference><Citation>Desmet F-O, Hamroun D, Lalande M, Collod-B&#xe9;roud G, Claustres M, B&#xe9;roud C. Human Splicing Finder: An online bioinformatics tool to predict splicing signals. Nucleic Acids Res. 2009;37:e67.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2685110</ArticleId><ArticleId IdType="pubmed">19339519</ArticleId></ArticleIdList></Reference><Reference><Citation>Raponi M, Kralovicova J, Copson E, Divina P, Eccles D, Johnson P, Baralle D, Vorechovsky I. Prediction of single-nucleotide substitutions that result in exon skipping: Identification of a splicing silencer in BRCA1 exon 6. Hum. Mutat. 2011;32:436&#x2013;444.</Citation><ArticleIdList><ArticleId IdType="pubmed">21309043</ArticleId></ArticleIdList></Reference><Reference><Citation>Reese MG, Eeckman FH, Kulp D, Haussler D. Improved splice site detection in Genie. J. Comput. Biol. J. Comput. Mol. Cell Biol. 1997;4:311&#x2013;323.</Citation><ArticleIdList><ArticleId IdType="pubmed">9278062</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashkenazy H, Abadi S, Martz E, Chay O, Mayrose I, Pupko T, Ben-Tal N. ConSurf 2016: An improved methodology to estimate and visualize evolutionary conservation in macromolecules. Nucleic Acids Res. 2016;44:W344&#x2013;W350.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4987940</ArticleId><ArticleId IdType="pubmed">27166375</ArticleId></ArticleIdList></Reference><Reference><Citation>Bendl J, Stourac J, Salanda O, Pavelka A, Wieben ED, Zendulka J, Brezovsky J, Damborsky J. PredictSNP: Robust and accurate consensus classifier for prediction of disease-related mutations. PLoS Comput. Biol. 2014;10:e1003440.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3894168</ArticleId><ArticleId IdType="pubmed">24453961</ArticleId></ArticleIdList></Reference><Reference><Citation>Johansen MB, Izarzugaza JMG, Brunak S, Petersen TN, Gupta R. Prediction of disease causing non-synonymous SNPs by the Artificial Neural Network Predictor NetDiseaseSNP. PloS One 2013;8:e68370.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3723835</ArticleId><ArticleId IdType="pubmed">23935863</ArticleId></ArticleIdList></Reference><Reference><Citation>Conchillo-Sol&#xe9; O, de Groot NS, Avil&#xe9;s FX, Vendrell J, Daura X, Ventura S. AGGRESCAN: A server for the prediction and evaluation of &#x2018;hot spots&#x2019; of aggregation in polypeptides. BMC Bioinform. 2007;8:65.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1828741</ArticleId><ArticleId IdType="pubmed">17324296</ArticleId></ArticleIdList></Reference><Reference><Citation>Linding R, Schymkowitz J, Rousseau F, Diella F, Serrano L. A comparative study of the relationship between protein structure and &#x3b2;-aggregation in globular and intrinsically disordered proteins. J. Mol. Biol. 2004;342:345&#x2013;353.</Citation><ArticleIdList><ArticleId IdType="pubmed">15313629</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuriata A, Iglesias V, Pujols J, Kurcinski M, Kmiecik S, Ventura S. Aggrescan3D (A3D) 2.0: Prediction and engineering of protein solubility. Nucleic Acids Res. 2019;47:W300&#x2013;W307.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6602499</ArticleId><ArticleId IdType="pubmed">31049593</ArticleId></ArticleIdList></Reference><Reference><Citation>Strange RW, Antonyuk SV, Hough MA, Doucette PA, Valentine JS, Hasnain SS. Variable metallation of human superoxide dismutase: Atomic resolution crystal structures of Cu-Zn, Zn-Zn and as-isolated wild-type enzymes. J. Mol. Biol. 2006;356:1152&#x2013;1162.</Citation><ArticleIdList><ArticleId IdType="pubmed">16406071</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen J, Wong CF, Subramaniam S, Albright TA, McCammon JA. Partial electrostatic charges for the active center of Cu, Zn superoxide dismutase. J. Comput. Chem. 1990;11:346&#x2013;350.</Citation></Reference><Reference><Citation>Branco RJF, Fernandes PA, Ramos MJ. Molecular dynamics simulations of the enzyme Cu, Zn superoxide dismutase. J. Phys. Chem. B. 2006;110:16754&#x2013;16762.</Citation><ArticleIdList><ArticleId IdType="pubmed">16913815</ArticleId></ArticleIdList></Reference><Reference><Citation>MacKerell AD, Banavali N, Foloppe N. Development and current status of the CHARMM force field for nucleic acids. Biopolymers. 2000;56:257&#x2013;265.</Citation><ArticleIdList><ArticleId IdType="pubmed">11754339</ArticleId></ArticleIdList></Reference><Reference><Citation>Kubo, R., Toda, M., Hashitsume, N. Statistical Physics II: Nonequilibrium Statistical Mechanics. 2nd edn. (Springer, 1991). 10.1007/978-3-642-58244-8.</Citation></Reference><Reference><Citation>Ryckaert J-P, Ciccotti G, Berendsen HJC. Numerical integration of the cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes. J. Comput. Phys. 1977;23:327&#x2013;341.</Citation></Reference><Reference><Citation>Udar N, Atilano SR, Brown DJ, Holguin B, Small K, Nesburn AB, Kenney MC. SOD1: A candidate gene for keratoconus. Investig. Ophthalmol. Vis. Sci. 2006;47:3345&#x2013;3351.</Citation><ArticleIdList><ArticleId IdType="pubmed">16877401</ArticleId></ArticleIdList></Reference><Reference><Citation>De Bonis P, Laborante A, Pizzicoli C, Stallone R, Barbano R, Longo C, Mazzilli E, Zelante L, Bisceglia L. Mutational screening of VSX1, SPARC, SOD1, LOX, and TIMP3 in keratoconus. Mol. Vis. 2011;17:2482&#x2013;2494.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3185016</ArticleId><ArticleId IdType="pubmed">21976959</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton AE, Chi&#xf2; A, Traynor BJ. State of play in amyotrophic lateral sclerosis genetics. Nat. Neurosci. 2014;17:17&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4544832</ArticleId><ArticleId IdType="pubmed">24369373</ArticleId></ArticleIdList></Reference><Reference><Citation>Radunovi&#x107; A, Leigh PN. ALSODatabase: Database of SOD1 (and other) gene mutations in ALS on the Internet. European FALS Group and ALSOD Consortium. Amyotroph. Lateral Scler. Mot. Neuron Disord. Off. Publ. World Fed. Neurol. Res. Group Mot. Neuron Dis. 1999;1:45&#x2013;49.</Citation><ArticleIdList><ArticleId IdType="pubmed">12371416</ArticleId></ArticleIdList></Reference><Reference><Citation>Marangi G, Traynor BJ. Genetic causes of amyotrophic lateral sclerosis: New genetic analysis methodologies entailing new opportunities and challenges. Brain Res. 2015;1607:75&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5916786</ArticleId><ArticleId IdType="pubmed">25316630</ArticleId></ArticleIdList></Reference><Reference><Citation>Ku&#x17a;ma-Kozakiewicz M, Berdy&#x144;ski M, Morita M, Takahashi Y, Kawata A, Kaida K-I, Ka&#x17a;mierczak B, Lusakowska A, Goto J, Tsuji S, Zekanowski C, Kwieci&#x144;ski H. Recurrent K3E mutation in Cu/Zn superoxide dismutase gene associated with amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Front. Degener. 2013;14:608&#x2013;614.</Citation><ArticleIdList><ArticleId IdType="pubmed">23898858</ArticleId></ArticleIdList></Reference><Reference><Citation>Alavi A, Nafissi S, Rohani M, Zamani B, Sedighi B, Shamshiri H, Fan J-B, Ronaghi M, Elahi E. Genetic analysis and SOD1 mutation screening in Iranian amyotrophic lateral sclerosis patients. Neurobiol. Aging. 2013;34(1516):e1&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">23062701</ArticleId></ArticleIdList></Reference><Reference><Citation>Chadi G, Maximino JR, de Jorge FMH, de Borba FC, Gilio JM, Callegaro D, Lopes CG, Santos SND, Rebelo GNS. Genetic analysis of patients with familial and sporadic amyotrophic lateral sclerosis in a Brazilian Research Center. Amyotroph. Lateral Scler. Front. Degener. 2017;18:249&#x2013;255.</Citation><ArticleIdList><ArticleId IdType="pubmed">27978769</ArticleId></ArticleIdList></Reference><Reference><Citation>Saeed M, Yang Y, Deng H-X, Hung W-Y, Siddique N, Dellefave L, Gellera C, Andersen PM, Siddique T. Age and founder effect of SOD1 A4V mutation causing ALS. Neurology. 2009;72:1634&#x2013;1639.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2683645</ArticleId><ArticleId IdType="pubmed">19176896</ArticleId></ArticleIdList></Reference><Reference><Citation>Ku&#x17a;ma-Kozakiewicz M, Andersen PM, Elahi E, Alavi A, Sapp PC, Morita M, &#x17b;ekanowski C, Berdy&#x144;ski M. Putative founder effect in the Polish, Iranian and United States populations for the L144S SOD1 mutation associated with slowly uniform phenotype of amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Front. Degener. 2020;22:1&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">32777948</ArticleId></ArticleIdList></Reference><Reference><Citation>Cudkowicz ME, McKenna-Yasek D, Sapp PE, Chin W, Geller B, Hayden DL, Schoenfeld DA, Hosler BA, Horvitz HR, Brown RH. Epidemiology of mutations in superoxide dismutase in amyotrophic lateral sclerosis. Ann. Neurol. 1997;41:210&#x2013;221.</Citation><ArticleIdList><ArticleId IdType="pubmed">9029070</ArticleId></ArticleIdList></Reference><Reference><Citation>Gamez J, Corbera-Bellalta M, Nogales G, Raguer N, Garc&#xed;a-Arum&#xed; E, Badia-Canto M, Llad&#xf3;-Carb&#xf3; E, &#xc1;lvarez-Sab&#xed;n J. Mutational analysis of the Cu/Zn superoxide dismutase gene in a Catalan ALS population: Should all sporadic ALS cases also be screened for SOD1? J. Neurol. Sci. 2006;247:21&#x2013;28.</Citation><ArticleIdList><ArticleId IdType="pubmed">16674979</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou L, Jiao B, Xiao T, Zhou L, Zhou Z, Du J, Yan X, Wang J, Tang B, Shen L. Screening of SOD1, FUS and TARDBP genes in patients with amyotrophic lateral sclerosis in central-southern China. Sci. Rep. 2016;6:32478.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5015023</ArticleId><ArticleId IdType="pubmed">27604643</ArticleId></ArticleIdList></Reference><Reference><Citation>Bystr&#xf6;m R, Andersen PM, Gr&#xf6;bner G, Oliveberg M. SOD1 mutations targeting surface hydrogen bonds promote amyotrophic lateral sclerosis without reducing apo-state stability. J. Biol. Chem. 2010;285:19544&#x2013;19552.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2885233</ArticleId><ArticleId IdType="pubmed">20189984</ArticleId></ArticleIdList></Reference><Reference><Citation>Naini A, Mehrazin M, Lu J, Gordon P, Mitsumoto H. Identification of a novel D109Y mutation in Cu/Zn superoxide dismutase (sod1) gene associated with amyotrophic lateral sclerosis. J. Neurol. Sci. 2007;254:17&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">17257622</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreira LGA, Pereira LC, Drummond PR, De Mesquita JF. Structural and functional analysis of human SOD1 in amyotrophic lateral sclerosis. PLoS&#xa0;One. 2013 doi: 10.1371/journal.pone.0081979.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0081979</ArticleId><ArticleId IdType="pmc">PMC3846731</ArticleId><ArticleId IdType="pubmed">24312616</ArticleId></ArticleIdList></Reference><Reference><Citation>Lodish H, Berk A, Zipursky SL, Matsudaira P, Baltimore D, Darnell J. Molecular Cell Biology. 4. Freeman; 2000.</Citation></Reference><Reference><Citation>Prudencio M, Hart PJ, Borchelt DR, Andersen PM. Variation in aggregation propensities among ALS-associated variants of SOD1: Correlation to human disease. Hum. Mol. Genet. 2009;18:3217&#x2013;3226.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2722984</ArticleId><ArticleId IdType="pubmed">19483195</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu C, Beck MV, Griffith JD, Deshmukh M, Dokholyan NV. Large SOD1 aggregates, unlike trimeric SOD1, do not impact cell viability in a model of amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. U. S. A. 2018;115:4661&#x2013;4665.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5939103</ArticleId><ArticleId IdType="pubmed">29666246</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J, Lee H, Lee JH, Kwon D, Genovesio A, Fenistein D, Ogier A, Brondani V, Grailhe R. Dimerization, oligomerization, and aggregation of human amyotrophic lateral sclerosis copper/zinc superoxide dismutase 1 protein mutant forms in live cells. J. Biol. Chem. 2014;289:15094&#x2013;15103.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4031559</ArticleId><ArticleId IdType="pubmed">24692554</ArticleId></ArticleIdList></Reference><Reference><Citation>de Brasil AA, de Carvalho MDC, Gerhardt E, Queiroz DD, Pereira MD, Outeiro TF, Eleutherio ECA. Characterization of the activity, aggregation, and toxicity of heterodimers of WT and ALS-associated mutant Sod1. Proc. Natl. Acad. Sci. 2019;116:25991&#x2013;26000.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6926019</ArticleId><ArticleId IdType="pubmed">31796595</ArticleId></ArticleIdList></Reference><Reference><Citation>Sannigrahi A, Chowdhury S, Das B, Banerjee A, Halder A, Kumar A, Saleem M, Naganathan AN, Karmakar S, Chattopadhyay K. The metal cofactor zinc and interacting membranes modulate SOD1 conformation-aggregation landscape in an in vitro ALS model. Elife. 2021;10:e61453.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8087447</ArticleId><ArticleId IdType="pubmed">33825682</ArticleId></ArticleIdList></Reference><Reference><Citation>Birve A, Neuwirth C, Weber M, Marklund SL, Nilsson A-C, Jonsson PA, Andersen PM. A novel SOD1 splice site mutation associated with familial ALS revealed by SOD activity analysis. Hum. Mol. Genet. 2010;19:4201&#x2013;4206.</Citation><ArticleIdList><ArticleId IdType="pubmed">20709807</ArticleId></ArticleIdList></Reference><Reference><Citation>Valdmanis PN, Belzil VV, Lee J, Dion PA, St-Onge J, Hince P, Funalot B, Couratier P, Clavelou P, Camu W, Rouleau GA. A mutation that creates a pseudoexon in SOD1 causes familial ALS. Ann. Hum. Genet. 2009;73:652&#x2013;657.</Citation><ArticleIdList><ArticleId IdType="pubmed">19847927</ArticleId></ArticleIdList></Reference><Reference><Citation>Belli M, Ramazzotti M, Chiti F. Prediction of amyloid aggregation in vivo. EMBO Rep. 2011;12:657&#x2013;663.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3128957</ArticleId><ArticleId IdType="pubmed">21681200</ArticleId></ArticleIdList></Reference><Reference><Citation>Brasil AA, Magalh&#xe3;es RSS, De Carvalho MDC, Paiva I, Gerhardt E, Pereira MD, Outeiro TF, Eleutherio ECA. Implications of fALS mutations on Sod1 function and oligomerization in cell models. Mol. Neurobiol. 2018;55:5269&#x2013;5281.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5948255</ArticleId><ArticleId IdType="pubmed">28884318</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A, Mazzini L, D&#x2019;Alfonso S, Corrado L, Canosa A, Moglia C, Manera U, Bersano E, Brunetti M, Barberis M, Veldink JH, van den Berg LH, Pearce N, Sproviero W, McLaughlin R, Vajda A, Hardiman O, Rooney J, Mora G, Calvo A, Al-Chalabi A. The multistep hypothesis of ALS revisited: The role of genetic mutations. Neurology. 2018;91:e635&#x2013;e642.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6105040</ArticleId><ArticleId IdType="pubmed">30045958</ArticleId></ArticleIdList></Reference><Reference><Citation>Keskin I, Birve A, Berdynski M, Hjertkvist K, Rofougaran R, Nilsson TK, Glass JD, Marklund SL, Andersen PM. Comprehensive analysis to explain reduced or increased SOD1 enzymatic activity in ALS patients and their relatives. Amyotroph. Lateral Scler. Front. Degener. 2017;18:457&#x2013;463.</Citation><ArticleIdList><ArticleId IdType="pubmed">28325066</ArticleId></ArticleIdList></Reference><Reference><Citation>Pansarasa O, Bordoni M, Diamanti L, Sproviero D, Gagliardi S, Cereda C. SOD1 in amyotrophic lateral sclerosis: &#x2018;Ambivalent&#x2019; behavior connected to the disease. Int. J. Mol. Sci. 2018 doi: 10.3390/ijms19051345.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms19051345</ArticleId><ArticleId IdType="pmc">PMC5983710</ArticleId><ArticleId IdType="pubmed">29751510</ArticleId></ArticleIdList></Reference><Reference><Citation>Genomes Project Consortium A global reference for human genetic variation. Nature. 2015;526:68&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4750478</ArticleId><ArticleId IdType="pubmed">26432245</ArticleId></ArticleIdList></Reference><Reference><Citation>Saccon RA, Bunton-Stasyshyn RKA, Fisher EMC, Fratta P. Is SOD1 loss of function involved in amyotrophic lateral sclerosis? Brain J. Neurol. 2013;136:2342&#x2013;2358.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3722346</ArticleId><ArticleId IdType="pubmed">23687121</ArticleId></ArticleIdList></Reference><Reference><Citation>Sau D, De Biasi S, Vitellaro-Zuccarello L, Riso P, Guarnieri S, Porrini M, Simeoni S, Crippa V, Onesto E, Palazzolo I, Rusmini P, Bolzoni E, Bendotti C, Poletti A. Mutation of SOD1 in ALS: A gain of a loss of function. Hum. Mol. Genet. 2007;16:1604&#x2013;1618.</Citation><ArticleIdList><ArticleId IdType="pubmed">17504823</ArticleId></ArticleIdList></Reference><Reference><Citation>Hug N, Longman D, C&#xe1;ceres JF. Mechanism and regulation of the nonsense-mediated decay pathway. Nucleic Acids Res. 2016;44:1483&#x2013;1495.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4770240</ArticleId><ArticleId IdType="pubmed">26773057</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu J, Chen K, Ni B, Li L, Chen G, Shi S. A novel SOD1 mutation in amyotrophic lateral sclerosis with a distinct clinical phenotype. Amyotroph. Lateral Scler. Off. Publ. World Fed. Neurol. Res. Group Mot. Neuron Dis. 2012;13:149&#x2013;154.</Citation><ArticleIdList><ArticleId IdType="pubmed">22185396</ArticleId></ArticleIdList></Reference><Reference><Citation>Zinman L, Liu HN, Sato C, Wakutani Y, Marvelle AF, Moreno D, Morrison KE, Mohlke KL, Bilbao J, Robertson J, Rogaeva E. A mechanism for low penetrance in an ALS family with a novel SOD1 deletion. Neurology. 2009;72:1153&#x2013;1159.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2680064</ArticleId><ArticleId IdType="pubmed">19332692</ArticleId></ArticleIdList></Reference><Reference><Citation>Canosa A, De Marco G, Lomartire A, Rinaudo MT, Di Cunto F, Turco E, Barberis M, Brunetti M, Casale F, Moglia C, Calvo A, Marklund SL, Andersen PM, Mora G, Chi&#xf2; A. A novel p.Ser108LeufsTer15 SOD1 mutation leading to the formation of a premature stop codon in an apparently sporadic ALS patient: Insights into the underlying pathomechanisms. Neurobiol. Aging. 2018;72:189.e11&#x2013;189.e17.</Citation><ArticleIdList><ArticleId IdType="pubmed">30236613</ArticleId></ArticleIdList></Reference><Reference><Citation>Gamez J, Caponnetto C, Ferrera L, Syriani E, Marini V, Morales M, Bordo D, Pirro C, Garre C, Origone P. I112M SOD1 mutation causes ALS with rapid progression and reduced penetrance in four Mediterranean families. Amyotroph. Lateral Scler. Off. Publ. World Fed. Neurol. Res. Group Mot. Neuron Dis. 2011;12:70&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pubmed">20515426</ArticleId></ArticleIdList></Reference><Reference><Citation>Khoris J, Moulard B, Briolotti V, Hayer M, Durieux A, Clavelou P, Malafosse A, Rouleau GA, Camu W. Coexistence of dominant and recessive familial amyotrophic lateral sclerosis with the D90A Cu, Zn superoxide dismutase mutation within the same country. Eur. J. Neurol. 2000;7:207&#x2013;211.</Citation><ArticleIdList><ArticleId IdType="pubmed">10809943</ArticleId></ArticleIdList></Reference><Reference><Citation>Pokrishevsky E, McAlary L, Farrawell NE, Zhao B, Sher M, Yerbury JJ, Cashman NR. Tryptophan 32-mediated SOD1 aggregation is attenuated by pyrimidine-like compounds in living cells. Sci. Rep. 2018;8:15590.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6197196</ArticleId><ArticleId IdType="pubmed">30349065</ArticleId></ArticleIdList></Reference><Reference><Citation>Baskoylu SN, Yersak J, Ohern P, Grosser S, Simon J, Kim S, Schuch K, Dimitriadi M, Yanagi KS, Lins J, Hart AC. Single copy/knock-in models of ALS SOD1 in C. elegans suggest loss and gain of function have different contributions to cholinergic and glutamatergic neurodegeneration. PLoS Genet. 2018;14:e1007682.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6200258</ArticleId><ArticleId IdType="pubmed">30296255</ArticleId></ArticleIdList></Reference><Reference><Citation>Park JH, Elpers C, Reunert J, McCormick ML, Mohr J, Biskup S, Schwartz O, Rust S, Gr&#xfc;neberg M, Seelh&#xf6;fer A, Schara U, Boltshauser E, Spitz DR, Marquardt T. SOD1 deficiency: A novel syndrome distinct from amyotrophic lateral sclerosis. Brain J. Neurol. 2019;142:2230&#x2013;2237.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6658856</ArticleId><ArticleId IdType="pubmed">31332433</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen PM, Nordstr&#xf6;m U, Tsiakas K, Johannsen J, Volk AE, Bierhals T, Zetterstr&#xf6;m P, Marklund SL, Hempel M, Santer R. Phenotype in an infant with SOD1 homozygous truncating mutation. N. Engl. J. Med. 2019;381:486&#x2013;488.</Citation><ArticleIdList><ArticleId IdType="pubmed">31314961</ArticleId></ArticleIdList></Reference><Reference><Citation>Amado DA, Davidson BL. Gene therapy for ALS: A review. Mol. Ther. 2021 doi: 10.1016/j.ymthe.2021.04.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ymthe.2021.04.008</ArticleId><ArticleId IdType="pmc">PMC8636154</ArticleId><ArticleId IdType="pubmed">33839324</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>